Contractual Allowable Versus Actual Payment Variance Detection
Catch silent underpayments before they disappear into contractual adjustments.
Staff Writer, Front-End Revenue Cycle
Deshawn reports on the patient-facing and intake side of infusion revenue cycle, drawing on his background as a referral coordinator and scheduling supervisor at a hospital-affiliated infusion suite. His reporting focuses on the operational handoffs that create downstream billing risk when they break down.
7 stories
Catch silent underpayments before they disappear into contractual adjustments.
Design denial workflows separately by root cause to match each problem to its actual fix.
Hospitals must document medical necessity upfront to survive site-of-care denials.
Procedural errors and coding gaps drive most biologic denials, not clinical disagreement.
Biologic infusion denials follow predictable patterns most practices never learn to read.
Medicare Advantage step therapy now blocks many infusions unless cheaper drugs fail first.
Documentation gaps and payer-specific rules drive most biologic PA denials, not clinical complexity.